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Abstract
The immune system protects us from foreign substances or pathogens by generating specific antibodies. The variety of
immunoglobulin (Ig) paratopes for antigen recognition is a result of the V(D)J rearrangement mechanism, while a fast and
efficient immune response is mediated by specific immunoglobulin isotypes obtained through class switch recombination
(CSR). To get a better understanding on how antibody-based immune protection works and how it changes with age, the
interdependency between these two parameters need to be addressed. Here, we have performed an in depth analysis of
antibody repertoires of 14 healthy donors representing different gender and age groups. For this task, we developed a
unique pyrosequencing approach, which is able to monitor the expression levels of all immunoglobulin V(D)J
recombinations of all isotypes including subtypes in an unbiased and quantitative manner. Our results show that donors
have individual immunoglobulin repertoires and cannot be clustered according to V(D)J recombination patterns, neither by
age nor gender. However, after incorporating isotype-specific analysis and considering CSR information into hierarchical
clustering the situation changes. For the first time the donors cluster according to age and separate into young adults and
elderly donors (.50). As a direct consequence, this clustering defines the onset of immune senescence at the age of fifty
and beyond. The observed age-dependent reduction of CSR ability proposes a feasible explanation why reduced efficacy of
vaccination is seen in the elderly and implies that novel vaccine strategies for the elderly should include the ‘‘Golden Agers’’.
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Introduction
The humoral immune system creates a vast diversity of
immunoglobulins (Ig) via rearrangements of variable- (V),
diversity- (D; only in heavy chain) and Joining- (J) gene segments
[1] to generate a pool of antibodies being able to bind to foreign
substances or pathogens (Figure 1). Once an antigen is entering the
body, an initial IgM-response is affinity-matured by somatic
hypermutation and is finally transferred into an immune response
mediated by specific immunoglobulin isotypes obtained through
class switch recombination (CSR) [2]. Hence, to get a better
understanding of antibody-based immune protection it is not
enough to assess V(D)J recombination, but the effector function of
an antibody encoded in the isotype is of equal importance. All
antibody classes have different functions and the switch from IgM/
IgD to a different isotype is a controlled and complex process [3].
In depth analysis of antibody repertoires of healthy donors
representing different age groups has not been performed yet,
although it is of major interest for the understanding of reduced
vaccination efficacy in elderly populations [4,5]. Recent findings
suggest that the dramatically reduced vaccination efficacy in
elderly populations is not because of a lack of specific antibodies
due to reduction of V(D)J recombination, but rather a problem in
antibody titre and lacking specificity in the right immunoglobulin
class to elicit an adequate response [6].
In our study we set out to monitor for the first time V(D)J
recombination patterns interrelated with Ig-isotype information on
an mRNA level using Next Generation Sequencing (NGS) in an
unbiased and quantitative manner. NGS has revolutionized the
research on antibody repertoires by providing a before unreached
amount of antibody sequences for analysis. NGS was first
employed for the analysis of Ig heavy chain repertoires in the
Zebrafish model [7,8]. Since then, multiple insights into the nature
of antibody diversity has been provided in an unrivalled depth
focusing on specific questions, however, primarily investigating
only into fractions of the Ig-repertoire [9–18]. Standard amplifi-
cation of Ig-repertoires from mRNA use many different V-gene
specific primers in parallel reactions to ensure completeness
[14,19,20]. To diminish possible primer-dependent bias [21], we
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developed a novel amplification strategy independent of V-gene
specific 59 primers. Further, our novel avenue of analysis is based
not only on information on V(D)J recombination but also on CSR
profiles of individual donors by incorporating isotype-specific
analysis of the antibody sequences. As a direct consequence,
donors clustered hierarchically according to age. For the first time
we could observe changes in immunoglobulin isotype repertoires
to be age-dependent indicating reduction of class switch recom-
bination ability already occurring at a much earlier time point
than expected.
Results and Discussion
Unbiased amplification and sequencing of human Ig-
repertoires
We have developed a novel amplification strategy for heavy and
light chain (HC and LC) repertoires starting from total RNA of
peripheral blood cells. We used a single V-gene independent 59
end adapter (PlugOligo) during reverse transcription in combina-
tion with five HC and two LC PCR primers derived from
conserved CH1/CL regions (Figure 1). CH1-specific primers were
chosen in such a way that the obtained sequences could be
subsequently subdivided into five isotypes with nine subtypes
(IgA1, -A2, -D, -E, -G1, -G2, -G3, -G4, -M). Since PCR-based
amplification processes can skew the Ig-repertoire, we developed a
‘‘single-pot’’ emulsion-based method for HC and LC amplification
to ensure unbiased amplification and maintenance of diversity
[21]. DNA sequencing of Ig-repertoires from 14 healthy Cauca-
sians of different age and gender was performed using a Roche
Genome Sequencer FLX/454 system [22]. In total 3,566,089
reads were obtained. The raw sequences were analyzed according
to three criteria (i) over 380 bp length, (ii) unique assignment to Ig-
class and (iii) unambiguous assignment of V(D)J rearrangements to
V-, D- and J-genes. For assignment of rearrangements we applied
the IMGT/High V-Quest tool [23–25] and for class assignment
we developed and employed a signature-based method indepen-
dent of the CH1-specific primers used for amplification. Classi-
fication of sequences was performed on a gene rather than allele
resolution using regular expression pattern matching of the
IMGT/High V-Quest output supplemented with a heuristic
approach to handle genes, which could not be identified
unambiguously. A relational data model was developed for
structural storage retrieval of both raw sequence data and analysis
results based on the PostgreSQL RDBMS.
In total, we obtained 1,357,978 (38.08%) sequences with a
complete and unambiguous set of V(D)J gene assignments of high
quality (1,046,521 HC and 295,555 LC). Our method allows the
unbiased analysis of V-gene usage in antibody repertoires and its
power is demonstrated by obtaining sequences of several V-genes,
e.g. IGHV3-13 and IGHV4-61, which have been missed in
previous deep sequencing studies where V-gene specific primers
were applied [12]. The analysis of light chain repertoires revealed
that the most frequently used kappa and lambda light chains over
all donors are IGKV1-39 and IGKV4-1 (14% and 13%) and
IGLV2-14 and IGLV1-40 of (22% and 8%), respectively.
Analysis of V(D)J recombination in healthy donors of
different age and gender
The description of V(D)J recombination frequencies to reflect
complete antibody repertoires is inherently complex. Looking only
at the combination of individual V-, D- and J-gene segments
independent of the resulting antibody sequence, we already found
6685 different VDJ recombination patterns for HC and 240
different VJ recombination patterns in LC. We performed
hierarchical clustering of the 14 donors based on the overall
distribution and relative frequency of these V(D)J recombination
Figure 1. Schematic illustration of immunoglobulin G in complex with antigen and mechanism of V(D)J recombination, as well as
amplification strategy for 454-sequencing. (A) Immunoglobulin-antigen interaction. Immunolgobulins recognize antigens via paratopes
primarily defined by complementarity determining regions (CDRs). VH: Variable heavy; VL: Variable light; CH1 Constant heavy 1; CL: Constant light. (B)
Representation of the genomic rearrangements occurring during V(D)J recombination. Chromosomal V(D)J rearrangement in the B-cell connect one
Variable-gene (V) with one Diversity (D; only HC) and one Joining-gene (J) out of a pool of different V(D)J genes to enable a high diversity of binding
affinities within the antibody repertoire. CDR 1 and 2 are defined by the V-genes, while CDR 3 is generated through V(D)J recombination. Constant
domains (CH and CL) specify the induced immune reaction. (C) Amplicon represent dsDNA fragments generated for pyrosequencing by emulsion
PCR (ePCR). PlugOligo: V-gene independent 59 end adapter for amplification.
doi:10.1371/journal.pone.0049774.g001
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in HC and LC and found neither age nor gender-specific grouping
(Figure 2). Next, we included isotype information and repeated the
clustering (Text S1). Again, no grouping was observed (Figure S1).
At the same time, however, we observed an overall tendency in the
usage of certain VDJ recombinations within the 14 individuals of
the cohort (Figure 3A) and analyzed the most frequent rearrange-
ments; those present 100-times over the median expression of all
VDJ recombination (.1.07%; Figure S2). These VDJ recombi-
nation patterns were predominantly found in only single isotypes
suggesting to have originated from oligoclonal expansion of B-cells
and, hence, reflecting natural diversification of specific immune
responses. The three most frequent VDJ-rearrangements were
analyzed in greater detail and strikingly, each of them could almost
exclusively be assigned to one major Ig-isotype. Donor I200091-
032 showed a distinct recombination pattern (VH4-34/D2-12/J4;
3.4%), of which 96% is expressed as IgA2 (Figure 3B). A detailed
analysis of the complementarity determining regions (CDRs) on
the amino acid level further revealed that 65% of this VDJ
rearrangement can be attributed to two sequences (54% and 11%,
respectively) that differ in a single amino acid. This could be either
a result of clonal expansion or of a kind of converging maturation
in response to an antigen. Donor I200091-030 has an elevated
VH2-5/D3-22/J4 recombination pattern (3.8%) with a frequency
of 95% in isotype A1 (Figure 3C). Detailed examination of CDR-
composition clearly suggests a polyclonal response since an even
distribution of seven different amino acid sequences contribute to
60% of this isotype recombination. In the third example (donor
I200091-21, Figure 3D), the most frequent recombination VH1-
2/D1-26/J3 (3.3%) was observed within IgG1 (89%). At the same
time we noticed in this donor a broad usage of VH1-2 (21.6%)
with different J and D segments over all V-genes of which the
majority was seen in IgG1 (17.6% of all). Altogether, IgG1
expression was 8 times over the median of all donors in this case
indicating a polyclonal or multi-antigenic immune response since
no distinct amino acid pattern was observed on the CDR-level.
Although none of the donors analyzed were vaccinated recently
and all were asymptomatic and without any recent or long-term
medical pre-history according to voluntary disclosure, the deter-
Figure 2. Hierarchical clustering of V(D)J recombination pattern distributions. (A) Clustering of HC VDJ rearrangements. (B) Clustering of
LC VJ rearrangements. Heatmaps show relative frequency of V(D)J recombination patterns (columns) versus donors (rows). Blue and pink colors
represent male and female, respectively. The age of the donor is recorded on the right. Individual V(D)J counts were normalized by total number of
sequences for each donor. Normalized frequencies were log-transformed [F as ln(F+1e-6)] and intensity was visualized from black to lime. Row and
column dendograms use euclidean distance.
doi:10.1371/journal.pone.0049774.g002
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mination of the Ig-repertoires by NGS already implies that our
method will be suitable to monitor V(D)J recombination patterns
in response to specific antigens/vaccines or during the course of
certain diseases, as suggested earlier [26].
Ig-isotype frequencies show age-dependency
Our method results in a quantitative overview of all isotypes and
their relative abundance, offering a detailed picture of the
immunoglobulin repertoire. At first we calculated for each donor
the relative amount of obtained sequences per isotype over the
total number of sequences. Most reads belonged to IgM (median
35.7%), whereas IgE- or IgG4-specific reads were rarely obtained.
Looking at the cohort as a whole, a correlation between IgM
(pval = 0.005) and IgD (pval = 0.029) expression levels and age of
the donors could readily be observed (Figure 4A; Table S1). After
dividing the donors into young adults (19–30 years) and elderly
(49–62 years) we found additionally a significant increase in the
IgM (pval = 0.029) and a concomitant decrease in IgG2
(pval = 0.027) levels as well as an uneven reduction in the other
isotypes among the elderly (except IgD and IgG4). At the same
time, no correlation between isotype distribution and age was
observed in the group of young adults (Tables S2 and S3). We
noticed that the antibody repertoire of the 24 years old male
resembles more that of elderly with a higher frequency of IgM and
IgD than the other young adults.
Differences in CSR-ability are observed between young
and elderly
We calculated the number of unique VDJ recombinations per
isotype in proportion to all isotypes for each donor (Figure S3). No
age dependency in the young adults was seen and the relative
number of unique VDJ recombinations for each isotype is
comparable within this group. In the group of elderly, however,
age dependency was clearly observed with a gradual increase in
relative numbers of VDJ recombination in IgM (pval = 0.006) and
IgD (pval = 0.003) and a significant decrease in IgG2
(pval = 0.011). This is in good agreement with the above finding
purely based on isotype analysis and clearly relates to the
biological function; i.e. dividing an immune reaction into initial
response (IgM/D) and specific response (IgA/E/G) after class
switch recombination (Figure 4B). Naı¨ve B-cells initially express
IgM or IgD through alternative mRNA splicing and only after
stimulation with antigens will the cells undergo CSR of the antigen
receptor resulting in IgA/E/G expressing B-cells through a
process of DNA rearrangement driven by enzymatic processes
[27]. CSR marks the onset of a specific response and results in
changes in immunoglobulin effector function while the specificity
of the immunoglobulin to the antigen, and hence variable domain
usage, remains largely unaffected. We observed in the elderly a
strong correlation between age and reduction in CSR ability
(correlation 0.95; pval = 0.004) and no correlation in the young
adults (pval = 0.663) (Tables S4, S5, S6).
Figure 3. In detail analysis of VDJ rearrangements. (A) Overall
distribution of VDJ rearrangements in 14 donors. (B) IgA2-specific VDJ
rearrangements in donor I200091-032. (C) IgA1-specific VDJ rearrange-
ments in donor I200091-030. (D) IgG1-specific VDJ rearrangements in
donor I200091-021. (E) Gauge; sphere volumes refer to their respective
numerical proportion. Less than 10 ppm are represented by a fixed size
sphere. Green color shading indicates number of reads constituting
respective recombination. Other colors highlight selected V-genes;
blue: IGHV1-2, yellow: IGHV2-5, red: IGHV4-34.
doi:10.1371/journal.pone.0049774.g003
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Hierarchical clustering segregates young and elderly
Finally, we compared the VDJ recombination patterns within
the donors with regards to CSR by analyzing the overlap between
VDJ recombination in the different isotypes. The results of the top
100 VDJ rearrangements between each isotype of a donor were
applied to cluster the donors hierarchically. The mean of the
overlap significantly differed in the young and elderly groups (p-
value = 0.0112; Welch two sample t-test) and a reduction in the
elderly of 35.52% (young: 0.1185; elderly: 0.0811) was observed,
clearly segregating the two age groups. The heat map in Figure 4C
shows that donors clustered according to age but not gender.
Below the age of fifty, the donors clustered in pairs age-
independently, while above fifty the donors with similar age
cluster pairwise suggesting correlation according to reduced CSR
ability. Clustering on the basis of single isotypes or group (e.g.
IgGs) only, revealed a tendency for age correlation (Figures S4, S5,
S6, S7). We conclude that only monitoring the complete
repertoire, now possible for the first time, can reveal donor-
specific implications of impairment of CSR and shed light into the
complexity of immune senescence in the elderly.
Analysis of changes in the VDJ rearrangement pattern
distribution by entropy
Additionally, entropy was used as a measure of dispersion
within the distribution of VDJ recombination for individual
donors. In order to minimize the influence of sample size (number
of available sequences) and the high number of possible
recombinations in regimes of small sample sizes entropy was
calculated according to the method of Chao and Shen [28], which
takes unobserved species into account and performs mostly
independent of sample sizes. Because entropy quantifies the
maximum information a distribution can comprise, it can be used
as another measure for the diversity of the antibody repertoire.
Calculations were carried out over all donors as well as over the
age groups separately (Tables S7, S8, S9, respectively). No
correlation or significant values were obtained for the young
adults. Consistent with the results for the variability, entropy is
Figure 4. Analyses based on Ig-isotype distributions. (A) Relative frequency of isotype-specific sequences within donors sorted left to right
according age. (B) Relative variability of isotypes on the basis of initial (IgM/D) and specific response (IgA/E/G). Variability: percentage of VDJs covered
by a distinct isotype in each donor. Variability VAD for antibody type A and donor D was calculated from the number of occurring VDJs nAD and the
total number of occurring VDJs in the donor D nD as nAD/nD. (C) Clustering of donors (rows) according to coincident appearance of most frequent VDJ
rearrangements in their isotypes (column) with age and gender. The hundred most frequently occurring VDJ rearrangements (or less if there were
less than hundred) for each donor and isotype were selected. For each donor the overlap between each pair of isotypes was quantified (visualized
from black to red) using the formula nboth/max(nA, nB), where nboth is the number of VDJs present in both sets of VDJs and nA and nB represent the
sizes of the sets. Blue and pink colors represent male and female, respectively.
doi:10.1371/journal.pone.0049774.g004
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increasing with age for the IgM and IgD isotypes (IgM,
pval = 0.034; IgD, pval = 0.005) and there is a decline in entropy
within the IgG2 isotype in the elderly (pval = 0.009). Thus, the
diversity of the immune response, particularly in the elderly, is
retained within the IgM/D isotype and not adequately transferred
to the IgG isotypes, which remain significantly less diverse (smaller
entropy). This can be attributed to reduced CSR.
The age of fifty and beyond marks the onset of immune
senescence
Age has a strong influence on the repertoire of the isotypes due
to onset of reduction of CSR from IgM/IgD to the more specific
and effective isotypes IgA and IgG, which are important not only
for rapid and efficient immune response to infectious agents [29]
but also for the induction of immune protection upon vaccination.
Decreased production of vaccine-specific antibodies rather than
VDJ recombination efficiency or avidity is thought to be
responsible for overall decrease of vaccine-efficacy [6], presumably
due to impairment of CD4+ helper cell responses [5]. We find that
immune senescence correlates with reduced CSR ability as a result
of reduced transcription of Ig-isotypes and that this process starts
around the age of fifty. This is in good agreement with reduced
vaccine efficacy in the older population [4–6,30–33]. Our results
are also in concordance with recent findings that suggest a
decrease in the number of mature activated B-cells and a
decreasing ability for CSR in elderly populations above sixty
years of age [34]. Mouse experiments suggest the molecular
mechanism of ageing in B-cells to be driven by TNF-a and low-
grade inflammation increasing with age. Subsequently this has a
negative effect on transcription factor E47 and activation-induced
cytidine deaminase and hence down-regulates CSR [35]. Note-
worthy is the relatively early onset of immune senescence. This
change in the immune system suggests itself to be influenced by
hormonal changes at this period of life [36]. Our findings on
immune senescence starting with the age of fifty calls for further
investigation in this direction as well as the development of
different treatment and vaccination procedures for the ‘‘Golden
Ager’’.
Materials and Methods
Medical history of healthy donors
The samples were collected from Caucasian donors living in the
Berlin area by in.vent Diagnostica GmbH (Hennigsdorf, Ger-
many) in the course of routine blood donation and represent
leftovers from infectious disease screening. According to German
Transfusion Law (Transfusionsgesetz - TFG) no ethical approval is
necessary if material is collected during such a routine process,
since no additional intervention is necessary. However, written
informed consent of the donors is mandatory and has been
obtained by all individuals for our specific research program. The
identity of the donors was made anonymous by in.vent
Diagnostica GmbH prior to sample transfer to the Max Planck
Institute for Molecular Genetics. Prior blood donation, the donors
stated to by free of any symptoms for at least 8 weeks and filled out
a questionnaire with 37 questions concerning the following areas:
previous vaccinations (,12 weeks), disease history in the areas of
neurology (,10 years), otorhinolaryngology, lung, cardiovascular,
liver, gastrointestinal tract (,10 years), pancreas, blood, cancer,
kidney, endocrinology, rheumatism, gynecology (,10 years), eyes,
serious infections (,10 years), skin, teeth, tropical diseases (e.g.
malaria), pregnancy and allergy. Further, medication status was
recorded for antibiotics, heart, blood clotting, diuretics, abstergent
agents, glucocorticosteroids, anti-diabetic, thyroid, contraceptive,
recreational and other drugs. Additionally, surgical interventions,
alcohol consumption and smoking habits were recorded, as well as
familial history of severe diseases, such as cancer and autoimmune
disorders (Table 1). After questionnaire evaluation, only donors
were finally included into the cohort who could answer the
majority of these questions with a no. Exclusion criteria were
predominantly fixed to disease or medication history, which could
influence the immune status of the donor.









in kg BMI& surgeries
I192158-77 26257 65770 62 m 180 90 27.8 none
I192158-80* 15566 63697 49 m 170 70 24.2 none
I192158-95* 10763 54175 21 f 164 53 19.7 none
I192158-105* 11620 16019 24 m 187 87 24.9 nasal septum, wisdom tooth
I200091-002 755 75863 57 f 175 80 26.1 caecum, biliary
I200091-004 0 62891 30 f 174 65 21.5 ankle
I200091-017 13960 95743 54 f 162 66 25.1 tonsils
I200091-021 19834 128861 20 m 184 83 24.5 none
I200091-023 91528 127206 19 m 187 87 24.9 small surgery at index finger
I200091-024 79339 94201 60 f 167 70 25.1 tonsils, caecum, cyst at ovary
I200091-028 1196 46102 52 m 180 80 24.7 hand, knee, nose, throat, caecum, hernia
inguinalis
I200091-030 13105 96308 22 m 180 86 26.5 none
I200091-032 2828 74597 20 f 167 57 20.4 nasal polyposis
I200091-0381 8804 45088 28 f 167 70 25.1 none
&BMI: body mass index;
*smoker;
1familial history of cardiac defect.
doi:10.1371/journal.pone.0049774.t001
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Sample preparation and sequencing
Reverse transcription and amplification of the mRNA was
performed using the MINT cDNA synthesis kit (Evrogen, Russia).
Immunoglobulin amplification was carried out in two independent
reactions for heavy and light chain, respectively. Ig-class specific
primers were pooled in an equal molar range to a final
concentration of 10 pmol/ml to allow chain and donor specific
ePCRs. ePCR conditions were as follows: initial heating at 98uC
for 45 sec and 15 cycles elongation (98uC for 10 sec, 65uC for
20 sec and 72uC for 22 sec) and finally 72uC for 4 min. The
amplicons were purified according a modified protocol [21] with a
DNA purification kit (Roboklon, Germany) and the ePCR was
repeated (additional 15 cycles). DNA was purified by 1.2% agarose
gel electrophoresis, enzymatically cleaved with SfiI and ligated
with self-made Roche454 adaptors containing appropriate SfiI-
sites (Knaust et al, submitted). Ligated DNA was repurified by
agarose gel electrophoresis and Agencourt AMPure XP. For
sequencing, the libraries were treated according to the manufac-
turer’s recommendation: bead-coupled amplification using the
‘‘GS FLX Titanium LV emPCR Kit’’ followed by sequencing
applying ‘‘GS FLX Titanium Sequencing Kit XLR70’’ and ‘‘GS
FLX Titanium PicoTiterPlate Kit’’.
Pattern search for Ig-isotype assignment
Isotypes were determined using a simplistic pattern matching
approach using isotype-specific signatures found in the constant
region of the different Ig-class (Table 2). Sequences of rearranged
antibodies were tested against these signatures using the
‘‘Fuzznuc’’ program from the EMBOSS [37] suite (Version
6.1.0) with default parameters. The output was further processed
using shell scripts to retrieve sequence identifiers to be saved in our
DBMS for further analysis. The pattern IgG2-01-02-03-04
recognizes both IgG2 and IgG4 while IgG4-01-04 is specific for
IgG4 alone – the intersection of sequences found by both patterns
is considered as IgG4 and the relative complement of IgG2-01-02-
03-04 in IgG4-01-04 as IgG2.
V(D)J assignment using IMGT/High V-Quest
Sequences (size selected, .380 bp) of the rearranged antibodies
obtained were submitted to the IMGT/HighV-QUEST high
throughput analysis portal with ‘‘allow insertions/deletions’’
option enabled. Output was filtered using following three steps:
(i) We only considered sequences which had a complete set of
V(D)J genes with a identity score greater than 85% and were
successfully assigned to an Ig-class by pattern matching against
isotype-specific signatures. (ii) IMGT/HighV-QUEST generated
output at the allele level. For our analyses however, we classified
sequences by gene. To convert alleles to genes, we applied a
regular expression filter on the IMGT identifiers (Protocol S1).
This filter merged different V, D or J-alleles into the respective
genes and treated duplicated and unduplicated D-genes as similar.
Additionally, a simple heuristic was employed to integrate some
genes which were hardly distinguishable from each other and
hence were often ambiguously assigned. (iii) As a last quality
control, all sequences were excluded, which were assigned to more
than one V, D or J-gene, respectively.
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Figure S1 VDJ recombination pattern distributions of
14 donors incorporating heavy chain isotype informa-
tion.
Figure S2 VDJ rearrangements 100-fold over the medi-
an frequency of all VDJ recombination patterns within
the cohort.
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recombination patterns in each isotype in proportion
to all isotypes within donors.
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IgM with all CSR-dependent isotypes.
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appearance of most frequent VDJ rearrangements in
IgM and IgG subisotypes.
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Figure S6 Clustering of donors according to coincident
appearance of most frequent VDJ rearrangements in
IgG with subisotypes of IgG and with IgM.
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Figure S7 Clustering of donors according to coincident
appearance of most frequent VDJ rearrangements in
IgM with IgA1 and IgA2.
(PDF)
Protocol S1 Regular expression filter used to integrate
IMGT/High V-Quest alleles into genes.
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Text S1 Supporting experimental data.
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Table S1 Statistical analysis of relative amount of
obtained sequences per isotype over the total number
of sequences from all 14 donors.
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Table S2 Statistical analysis of relative amount of
obtained sequences per isotype over the total number
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Table S4 Unique VDJ recombination per isotype in
proportion to all isotypes in all donors.
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Table S5 Unique VDJ recombination per isotype in
proportion to all isotypes in young donors.
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Table S6 Unique VDJ recombination per isotype in
proportion to all isotypes in elderly donors.
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Table S7 Analysis of changes in the VDJ rearrangement
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